Melanoma is the cancer type in which RIPK4 is second mostly being mutated, with an average mutation rate of around 4% based on the curated data of the cBio Portal (https://www.cbioportal.org) and COSMIC database (https://cancer.sanger.ac.uk/cosmic). The gene discussed is RIPK4; the disease is melanoma.